Professor Cherry Wainright, adviser to ananda developments plc

Professor Cherry L Wainwright

Cherry graduated from the University of Aberdeen with a BSc (Hons) in Pharmacology and subsequently the University of Strathclyde with a PhD in Cardiovascular Pharmacology.  Her research career spans more than 42 years, with over 20 years spent at Strathclyde University before moving to Robert Gordon University in Aberdeen where she spent 8 years as the Director of the multi-disciplinary Institute for Health & Wellbeing Research and was the lead in Cardiometabolic Health Research and Co-Director of the Centre for Natural Products in Health. 

Throughout her career, Cherry has worked continuously in collaboration with Industry conducting research on the identification of novel therapeutic targets of cardiovascular diseases.  For the last 20 years her focus has been on the influence of endocannabinoids and phytocannabinoids on various cardiovascular disorders (ischaemia/reperfusion, cardiac fibrosis), vascular (atherosclerosis, restenosis) injury and cardiac energy regulation. 

Cherry has published around 100 full original articles and invited reviews and has 3 patents.  She is a Fellow of the British Pharmacological Society, for which is currently President Elect. 

Katie Sloper, adviser to Ananda Developments plc

Katie Sloper

Katie graduated from the University of New England with a BSc in Biochemistry, Microbiology and Nutrition, receiving several university Prizes for Excellence. Katie was then the recipient of the University Medal at the Australian National University (ANU) for her Honours thesis on DNA damage repair pathways. Katie subsequently completed her PhD at ANU with a focus on cancer research, before completing postdoctoral fellowships in both Australia and the USA.

In addition to her medical research Katie has over 15 years working in healthcare across both public and private sectors, including as a Senior Policy Advisor to the Queensland Minister for Health and a Member of the Pharmacy Board of Australia.

Katie’s medical research has recently focussed on understanding the therapeutic profile of medicinal cannabis and investigating innovative approaches to cancer treatment.

Vitalii Ratushnyi

Vitalii holds a Master of Business Administration from the Kyiv University of Technology and Design, where he majored in Computer Science and minored in Behavioural Psychology. Vitalii has nine years of experience in the technology sector, beginning his career as a Data Engineer and Solution Architect for several Israeli companies. He has also been a foundational engineer in various start-ups, bringing his unique perspective and technical skills to the forefront of innovation. Vitalii currently works at an investment fund, where he creates quantitative models and tools to support investment decisions.